Correction: Felsenstein M. et al. Perineural Invasion in Pancreatic Ductal Adenocarcinoma (PDAC): A Saboteur of Curative Intended Therapies? J. Clin. Med. 2022, 11, 2367
- PMID: 37959421
- PMCID: PMC10650003
- DOI: 10.3390/jcm12216947
Correction: Felsenstein M. et al. Perineural Invasion in Pancreatic Ductal Adenocarcinoma (PDAC): A Saboteur of Curative Intended Therapies? J. Clin. Med. 2022, 11, 2367
Abstract
In the original publication [...].
Erratum for
-
Perineural Invasion in Pancreatic Ductal Adenocarcinoma (PDAC): A Saboteur of Curative Intended Therapies?J Clin Med. 2022 Apr 23;11(9):2367. doi: 10.3390/jcm11092367. J Clin Med. 2022. PMID: 35566494 Free PMC article.
References
-
- Felsenstein M., Lindhammer F., Feist M., Hillebrandt K.H., Timmermann L., Benzing C., Globke B., Zocholl D., Hu M., Fehrenbach U., et al. Perineural Invasion in Pancreatic Ductal Adenocarcinoma (PDAC): A Saboteur of Curative Intended Therapies? J. Clin. Med. 2022;11:2367. doi: 10.3390/jcm11092367. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources